Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Reprod Domest Anim ; 48(4): 691-8, 2013 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-23369109

RESUMO

Although thyroid dysfunction occurs frequently in humans and some animal species, the mechanisms by which hypo- and hyperthyroidism affect the corpus luteum have not been thoroughly elucidated. This study evaluated the levels of proliferative activity, angiogenesis, apoptosis and expression of cyclooxygenase-2 in the corpus luteum of female rats with thyroid dysfunction. These processes may be important in understanding the reproductive changes caused by thyroid dysfunction. A total of 18 adult female rats were divided into three groups (control, hypothyroid and hyperthyroid) with six animals per group. Three months after treatment to induce thyroid dysfunction, the rats were euthanized in the dioestrus phase. The ovaries were collected and immunohistochemically analysed for expression of the cell proliferation marker CDC-47, vascular endothelial growth factor (VEGF), VEGF receptor Flk-1 and cyclooxygenase-2 (COX-2). Apoptosis was evaluated using the TUNEL assay. Hypothyroidism reduced the intensity and area of COX-2 expression in the corpus luteum (p < 0.05), while hyperthyroidism did not alter COX-2 expression in the dioestrus phase. Hypothyroidism significantly reduced the expression of CDC-47 in endothelial cells and pericytes in the corpus luteum, whereas hyperthyroidism did not induce a detectable change in CDC-47 expression (p > 0.05). Hypothyroidism reduced the level of apoptosis in luteal cells (p < 0.05) and increased VEGF expression in the corpus luteum. In contrast, hyperthyroidism increased the level of apoptosis in the corpus luteum (p < 0.05). In conclusion, thyroid dysfunction differentially affects the levels of proliferative activity, angiogenesis and apoptosis and COX-2 expression in the corpus luteum of female rats.


Assuntos
Corpo Lúteo/patologia , Corpo Lúteo/fisiopatologia , Ciclo-Oxigenase 2/análise , Hipertireoidismo/fisiopatologia , Hipotireoidismo/fisiopatologia , Animais , Apoptose , Proliferação de Células , Corpo Lúteo/química , Feminino , Hipertireoidismo/induzido quimicamente , Hipertireoidismo/patologia , Hipotireoidismo/induzido quimicamente , Hipotireoidismo/patologia , Imuno-Histoquímica , Marcação In Situ das Extremidades Cortadas , Componente 7 do Complexo de Manutenção de Minicromossomo/análise , Neovascularização Fisiológica , Propiltiouracila/administração & dosagem , Ratos , Ratos Wistar , Tiroxina/administração & dosagem , Tiroxina/sangue , Fator A de Crescimento do Endotélio Vascular/análise , Receptor 2 de Fatores de Crescimento do Endotélio Vascular/análise
2.
Arq. bras. med. vet. zootec ; 62(4): 812-815, Aug. 2010. ilus
Artigo em Inglês | LILACS | ID: lil-562046

RESUMO

A case of mammary carcinosarcoma is reported in a 13-year-old, mixed breed female cat, which was not spayed and had not received contraceptives. The patient presented extensive and coalescent nodules in all mammary glands. Based on the histological and immunohistochemical findings, the diagnosis of mammary carcinosarcoma was confirmed.


Descreve-se um caso de carcinossarcoma mamário em uma gata, sem raça definida, de 13 anos de idade. A gata não era castrada e não recebeu anticoncepcionais. A paciente apresentou extensivos e coalescentes nódulos em todas as glândulas mamárias. Com base nos achados histológicos e imunoistoquímicos, firmou-se o diagnóstico de carcinossarcoma da glândula mamária.


Assuntos
Animais , Feminino , Gatos , Carcinossarcoma/diagnóstico , Neoplasias Mamárias Animais/diagnóstico , Neoplasias Mamárias Animais , Carcinossarcoma/veterinária , Doenças Raras/veterinária , Histologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...